By Daily Touch Insights Editorial Team
Editorial Team
View Journalist Profile
SPACE & TECHNOLOGY — SpaceMD is preparing to take pharmaceutical research further into orbit after signing a contract for a dedicated mission aboard SpaceX's Starfall spacecraft, creating a new opportunity to study and develop medicines in the unique environment of microgravity.
SpaceMD, a wholly owned subsidiary of Redwire, plans to use the 2028 Starfall mission to fly as many as 32 Pharmaceutical In-Space Laboratory, or PIL-BOX, units designed to study drug compounds in microgravity before returning them to Earth for further analysis. 0
The mission represents a major expansion of SpaceMD's existing work in space-based pharmaceutical research and could help increase the scale and frequency of experiments conducted outside Earth.
A Dedicated Pharmaceutical Mission
The planned Starfall flight is significant because SpaceMD will have an entire commercial mission dedicated to its pharmaceutical research.
The company has previously sent its PIL-BOX laboratories to the International Space Station, but the Starfall mission will provide substantially more dedicated capacity for microgravity experiments.
Up to 32 PIL-BOX units are expected to fly on the 2028 mission, making it one of the largest dedicated commercial microgravity research missions announced to date.
Why Make Medicines in Space?
Microgravity can change how molecules behave and how crystals form.
On Earth, gravity can influence the formation and structure of pharmaceutical crystals. In microgravity, researchers can study crystal growth under different conditions that are difficult or impossible to reproduce on the ground.
The objective is not simply to manufacture medicines in space because it sounds futuristic.
The larger goal is to determine whether space-based research can produce pharmaceutical compounds with properties that could improve medicines developed for patients on Earth.
SpaceMD Has Already Tested the Technology
The Starfall mission is not the beginning of SpaceMD's work in orbit.
The company says 54 PIL-BOX systems have already flown to the International Space Station since 2023, with the systems used to crystallize pharmaceutical compounds.
According to SpaceMD, those experiments have produced crystals from 45 different compounds, demonstrating that the company has already accumulated significant experience with pharmaceutical research in microgravity.
The New PIL-BOX Will Be Designed for Starfall
SpaceMD is developing a new version of its PIL-BOX specifically for the Starfall spacecraft.
The redesigned system will be adapted to take advantage of Starfall's available mission duration and microgravity environment.
This could allow researchers to conduct larger numbers of experiments and gather more data from each mission.
Starfall Opens a New Commercial Opportunity
SpaceX's Starfall spacecraft is designed to provide access to microgravity for research, manufacturing and testing before returning payloads to Earth.
For pharmaceutical companies, that combination is particularly valuable because experiments can be conducted in orbit and then recovered for detailed laboratory analysis on the ground.
That creates a complete research cycle: send the compounds into space, expose them to microgravity, return the samples and examine the results on Earth.
The Pharmaceutical Industry Could Become a Major Space Customer
Space-based pharmaceutical research has attracted growing interest because certain biological and chemical processes can behave differently in microgravity.
If those differences can be translated into better drug formulations or manufacturing processes, pharmaceutical companies could eventually become important customers for commercial space infrastructure.
That would create a new business model for the space industry — not simply launching satellites, but providing specialised environments for companies developing products for Earth.
The Research Could Target Major Diseases
SpaceMD's previous work has included compounds associated with areas such as cancer, cardiovascular disease, obesity and diabetes, according to company information reported following the Starfall announcement.
The research does not mean that new treatments for these diseases are guaranteed.
Instead, the experiments are intended to investigate whether microgravity can produce useful changes in pharmaceutical compounds that researchers can then study further on Earth.
Space Manufacturing Is Moving Beyond Experiments
For years, manufacturing in space was largely treated as an experimental concept.
The Starfall mission points toward a more commercial model in which companies purchase dedicated orbital capacity for specific research and manufacturing objectives.
If these missions become more frequent and affordable, space could gradually become another location for specialised industrial production.
Why Returning the Materials to Earth Matters
SpaceMD's experiments are not designed to remain in orbit indefinitely.
The samples need to return to Earth so scientists can compare the space-grown materials with those produced under conventional conditions.
That makes a reusable or recoverable spacecraft particularly useful for pharmaceutical research.
Researchers can perform the experiment in space while retaining access to the physical samples afterward.
The 2028 Mission Is an Important Test
The planned launch will be an important test of whether dedicated commercial microgravity research can operate at a much larger scale.
SpaceMD will need to prepare its new PIL-BOX system, integrate the experiments with Starfall and ensure that the pharmaceutical samples can be safely recovered for analysis.
The success of the mission could influence how pharmaceutical companies view commercial space research.
SpaceX Gets a New Type of Customer
The agreement also demonstrates the expanding range of potential customers for SpaceX's space infrastructure.
Pharmaceutical research is fundamentally different from traditional satellite launches.
Instead of simply delivering hardware into orbit, the spacecraft becomes part of an industrial research process.
If the model works, pharmaceutical companies could eventually share the space economy with satellite operators, semiconductor manufacturers and materials researchers.
The Economics Still Need to Be Proven
There is an important question behind the excitement: can space-based pharmaceutical research become commercially worthwhile?
Launching experiments into orbit remains expensive, and microgravity research must demonstrate benefits that justify those costs.
A successful experiment is therefore only the beginning.
Pharmaceutical companies will ultimately want evidence that discoveries made in space can lead to better products, faster development or more efficient manufacturing on Earth.
Our Perspective
SpaceMD's Starfall mission is interesting because it moves the idea of space pharmaceuticals away from science fiction and toward a commercial operating model.
The company has already accumulated experience through dozens of experiments on the International Space Station. The next challenge is scaling that work and demonstrating that microgravity can create meaningful advantages for pharmaceutical development.
The real breakthrough will not be simply making pharmaceutical crystals in space. It will be proving that something discovered or manufactured in orbit can ultimately make a measurable difference to medicine on Earth.
Conclusion
SpaceMD plans to use SpaceX's Starfall spacecraft for a dedicated pharmaceutical research mission scheduled for 2028, with up to 32 PIL-BOX laboratories expected to fly aboard the spacecraft.
The mission builds on SpaceMD's previous microgravity research aboard the International Space Station and could significantly increase the scale of pharmaceutical experiments conducted in orbit.
If successful, the project could help establish pharmaceutical development as one of the emerging commercial uses of space.
The bigger opportunity is clear: space may eventually become not just a place to explore, but a specialised laboratory for creating better products and medicines for people on Earth.
